PREGABALIN LAPL pregabalin 50 mg capsule blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
26-11-2017

有効成分:

pregabalin, Quantity: 50 mg

から入手可能:

Lupin Australia Pty Limited

INN(国際名):

Pregabalin

医薬品形態:

Capsule, hard

構図:

Excipient Ingredients: pregelatinised maize starch; purified talc; titanium dioxide; purified water; Gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute

投与経路:

Oral

パッケージ内のユニット:

20, 14, 56, 60

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

製品概要:

Visual Identification: Size '4' capsules with white cap and white body, imprinted with "PG" on the cap and with a band and with "50" on the body in black ink, containing white to off white powder; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

認証ステータス:

Licence status A

承認日:

2014-12-05